Ahmed El Bastawisy

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim et al. · Journal of Clinical Oncology · 2024 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer

ABEER BAHHNASSY, Marwa Mohanad, Sabry Shaarawy et al. · Molecular Medicine Reports · 2015 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +16

Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt

Abeer A. Bahnassy, Marwa Mohanad, Manal F. Ismail et al. · Experimental and Molecular Pathology · 2015 · 34 citations

Medicine, Molecular Medicine, Oncology +13

Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer

Nada Ezzeldin, Dalia El-Lebedy, Amira Darwish et al. · Genes and Environment · 2017 · 30 citations · Full text

Medicine, Genetics, Oncology +17

The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion

Danielle Bogan, Lucio Meile, Ahmed El Bastawisy et al. · BMC Cancer · 2017 · 19 citations · Full text

Medicine, Cancer Biology, Oncology +11